These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10218868)

  • 1. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor.
    Peterson PK; Gekker G; Hu S; Lokensgard J; Portoghese PS; Chao CC
    Neuropharmacology; 1999 Feb; 38(2):273-8. PubMed ID: 10218868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein activation by endomorphins in the mouse periaqueductal gray matter.
    Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
    J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I.
    Burford NT; Tolbert LM; Sadee W
    Eur J Pharmacol; 1998 Jan; 342(1):123-6. PubMed ID: 9544801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
    Connor M; Schuller A; Pintar JE; Christie MJ
    Br J Pharmacol; 1999 Apr; 126(7):1553-8. PubMed ID: 10323586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
    Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptor.
    Hosohata K; Burkey TH; Alfaro-Lopez J; Varga E; Hruby VJ; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1998 Apr; 346(1):111-4. PubMed ID: 9617760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.
    McConalogue K; Grady EF; Minnis J; Balestra B; Tonini M; Brecha NC; Bunnett NW; Sternini C
    Neuroscience; 1999 Mar; 90(3):1051-9. PubMed ID: 10218804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
    Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
    Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy.
    Al-Khrasani M; Orosz G; Kocsis L; Farkas V; Magyar A; Lengyel I; Benyhe S; Borsodi A; Rónai AZ
    Eur J Pharmacol; 2001 Jun; 421(1):61-7. PubMed ID: 11408050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
    Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
    Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
    Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
    Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
    Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
    Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu-opioid and GABA(B) receptors modulate different types of Ca2+ currents in rat nodose ganglion neurons.
    Rusin KI; Moises HC
    Neuroscience; 1998 Aug; 85(3):939-56. PubMed ID: 9639286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel stimulations of in vitro and in situ [35S]GTPgammaS binding by endomorphin 1 and DAMGO in mouse brains.
    Kakizawa K; Shimohira I; Sakurada S; Fujimura T; Murayama K; Ueda H
    Peptides; 1998; 19(4):755-8. PubMed ID: 9622032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro.
    Stiene-Martin A; Hauser KF
    J Neurosci Res; 1991 Aug; 29(4):538-48. PubMed ID: 1665190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.